Telix Pharmaceuticals
TLX.AX
#2493
Rank
ยฃ4.33 B
Marketcap
ยฃ12.94
Share price
-3.87%
Change (1 day)
122.43%
Change (1 year)

P/E ratio for Telix Pharmaceuticals (TLX.AX)

P/E ratio at the end of 2022: -20.1

According to Telix Pharmaceuticals's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -73.0166. At the end of 2022 the company had a P/E ratio of -20.1.

P/E ratio history for Telix Pharmaceuticals from 2017 to 2022

PE ratio at the end of each year

Year P/E ratio Change
2022-20.1-13.42%
2021-23.227.69%
2020-18.154.16%
2019-11.838.34%
2018-8.51-15.46%
2017-10.1

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.